Clinical and morphological correlations in acute ischemic stroke

Romanian Journal of Morphology and Embryology

Volumn 53, Issue 4, 2012, Pages 917-926

  Slujitoru, Anca Ştefania ^a   Enache, Andreea Lorena ^a   Pintea, Irina L ^a   Rolea, Elisabeta ^a   Stocheci, Cristina Mariana ^a   Pop, O T ^a   Predescu, Anca ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Acute ischemic stroke; Correlations; Histopathology; Predictors

Indexed keywords

AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY;

AGED; BRAIN ISCHEMIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; STROKE;

EID: 84872224154     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Lo EH, Dalkara T, Moskowitz MA, Mechanisms, challenges and opportunities in stroke, Nat Rev Neurosci, 2003, 4(5): 399-415.
2. Adams HP Jr, Guidelines for the management of patients with acute ischemic stroke: a synopsis. A Special Writing Group of the Stroke Council, American Heart Association, Heart Dis Stroke, 1994, 3(6):407-411.
3. Flynn RW, MacWalter RS, Doney AS, The cost of cerebral ischaemia, Neuropharmacology, 2008, 55(3):250-256.
4. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data, Lancet, 2006, 367(9524):1747-1757.
5. Mena H, Cadavid D, Rushing EJ, Human cerebral infarct: a proposed histopathologic classification based on 137 cases, Acta Neuropathol, 2004, 108(6):524-530.
6. Brainin M, Bornstein N, Boysen G, Demarin V, Acute neurological stroke care in Europe: results of the European Stroke Care Inventory, Eur J Neurol, 2000, 7(1):5-10.
7. Ito U, Kuroiwa T, Hanyu S, Hakamata Y, Kawakami E, Nakano I, Oyanagi K, Temporal profile of experimental ischemic edema after threshold amount of insult to induce infarction - ultrastructure, gravimetry and Evans' blue extravasation, Acta Neurochir Suppl, 2003, 86:131-135.
8. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P, Stroke, Lancet, 2003, 362(9391):1211-1224.
9. Kelly PJ, Hedley-Whyte ET, Primavera J, He J, Gonzalez RG, Diffusion MRI in ischemic stroke compared to pathologically verified infarction, Neurology, 2001, 56(7):914-920.
10. Jellinger KA, The pathology of ischemic-vascular dementia: an update, J Neurol Sci, 2002, 203-204:153-157.
11. Weimar C, Roth MP, Zillessen G, Glahn J, Wimmer ML, Busse O, Haberl RL, Diener HC; German Stroke Date Bank Collaborators, Complications following acute ischemic stroke, Eur Neurol, 2002, 48(3):133-140.
12. Nedeltchev K, Renz N, Karameshev A, Haefeli T, Brekenfeld C, Meier N, Remonda L, Schroth G, Arnold M, Mattle HP, Predictors of early mortality after acute ischaemic stroke, Swiss Med Wkly, 2010, 140(17-18):254-259.
13. Anderson CS, Jamrozik KD, Stewart-Wynne EG, Predicting survival after stroke: experience from the Perth Community Stroke Study, Clin Exp Neurol, 1992, 29:117-128.
14. Członkowska A, Ryglewicz D, Lechowicz W, Basic analytical parameters as the predictive factors for 30-day case fatality rate in stroke, Acta Neurol Scand, 1997, 95(2):121-124.
15. Castillo J, Dávalos A, Marrugat J, Noya M, Timing for fever-related brain damage in acute ischemic stroke, Stroke, 1998, 29(12):2455-2460.
16. Smithard DG, O'Neill PA, Parks C, Morris J, Complications and outcome after acute stroke. Does dysphagia matter? Stroke, 1996, 27(7):1200-1204.
17. Wang Y, Lim LL, Levi C, Heller RF, Fischer J, A prognostic index for 30-day mortality after stroke, J Clin Epidemiol, 2001, 54(8):766-773.
18. Turaj W, Słowik A, Szczudlik A, Factors related to the occurrence of hyperthermia in patients with acute ischaemic stroke and with primary intracerebral haemorrhage, Neurol Neurochir Pol, 2008, 42(4):316-322.
19. Aslanyan S, Fazekas F, Weir CJ, Horner S, Lees KR; GAIN International Steering Committee and Investigators, Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN International Trial, Stroke, 2003, 34(10):2420-2425.
20. Castillo J, Leira R, García MM, Serena J, Blanco M, Dávalos A, Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome, Stroke, 2004, 35(2):520-526.
21. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA; IST Collaborative Group, Blood pressure and clinical outcomes in the International Stroke Trial, Stroke, 2002, 33(5):1315-1320.
22. Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J, Decreased mortality by normalizing blood glucose after acute ischemic stroke, Acad Emerg Med, 2006, 13(2):174-180.
23. Kimura K, Minematsu K, Yamaguchi T; Japan Multicenter Stroke Investigators' Collaboration (J-MUSIC), Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke, J Neurol Neurosurg Psychiatry, 2005, 76(5):679-683.
24. Stead LG, Gilmore RM, Decker WW, Weaver AL, Brown RD Jr, Initial emergency department blood pressure as predictor of survival after acute ischemic stroke, Neurology, 2005, 65(8):1179-1183.
25. Stöllberger C, Exner I, Finsterer J, Slany J, Steger C, Stroke in diabetic and non-diabetic patients: course and prognostic value of admission serum glucose, Ann Med, 2005, 37(5): 357-364.
26. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R, 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs, Arch Neurol, 1996, 53(4):309-315.
27. Qureshi AI, Suarez JI, Yahia AM, Mohammad Y, Uzun G, Suri MF, Zaidat OO, Ayata C, Ali Z, Wityk RJ, Timing of neurologic deterioration in massive middle cerebral artery infarction: a multicenter review, Crit Care Med, 2003, 31(1): 272-277.
28. Bamford J, Dennis M, Sandercock P, Burn J, Warlow C, The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project, J Neurol Neurosurg Psychiatry, 1990, 53(10):824-829.
29. Broderick JP, Phillips SJ, O'Fallon WM, Frye RL, Whisnant JP, Relationship of cardiac disease to stroke occurrence, recurrence, and mortality, Stroke, 1992, 23(9): 1250-1256.
30. Brown AW, Brierley JB, Anoxic-ischaemic cell change in rat brain light microscopic and fine-structural observations, J Neurol Sci, 1972, 16(1):59-84.
31. Hossmann KA, Disturbances of cerebral protein synthesis and ischemic cell death, Prog Brain Res, 1993, 96:161-177.
32. Beghi E, Bogliun G, Cavaletti G, Sanguineti I, Tagliabue M, Agostoni F, Macchi I, Hemorrhagic infarction: risk factors, clinical and tomographic features, and outcome. A case-control study, Acta Neurol Scand, 1989, 80(3):226-231.
33. Wang CX, Shuaib A, Critical role of microvasculature basal lamina in ischemic brain injury, Prog Neurobiol, 2007, 83(3): 140-148.
34. Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, Kiefer R, Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice, Exp Neurol, 2003, 183(1):25-33.
35. Tanaka R, Komine-Kobayashi M, Mochizuki H, Yamada M, Furuya T, Migita M, Shimada T, Mizuno Y, Urabe T, Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia, Neuroscience, 2003, 117(3):531-539.
36. 11C]PK11195 and positron emission tomography in patients after ischemic stroke, Neuroreport, 2000, 11(13):2957-2960.
37. Price CJ, Menon DK, Peters AM, Ballinger JR, Barber RW, Balan KK, Lynch A, Xuereb JH, Fryer T, Guadagno JV, Warburton EA, Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study, Stroke, 2004, 35(7):1659-1664.
38. Buck BH, Liebeskind DS, Saver JL, Bang OY, Yun SW, Starkman S, Ali LK, Kim D, Villablanca JP, Salamon N, Razinia T, Ovbiagele B, Early neutrophilia is associated with volume of ischemic tissue in acute stroke, Stroke, 2008, 39(2):355-360.
39. Sugawara T, Lewén A, Gasche Y, Yu F, Chan PH, Overexpression of SOD1 protects vulnerable motor neurons after spinal cord injury by attenuating mitochondrial cyto-chrome c release, FASEB J, 2002, 16(14):1997-1999.
40. Arsene D, Vasilescu F, Toader C, Bǎlan A, Popa C, Ardeleanu C, Clinico-pathological correlations in fatal ischemic stroke. An immunohistochemical study of human brain penumbra, Rom J Morphol Embryol, 2011, 52(1):29-38.
41. Kerr LE, McGregor AL, Amet LE, Asada T, Spratt C, Allsopp TE, Harmar AJ, Shen S, Carlson G, Logan N, Kelly JS, Sharkey J, Mice overexpressing human caspase 3 appear phenotypically normal but exhibit increased apoptosis and larger lesion volumes in response to transient focal cerebral ischaemia, Cell Death Differ, 2004, 11(10):1102-1111.
42. Nimmerjahn A, Kirchhoff F, Helmchen F, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, 2005, 308(5726):1314-1318.
43. Dahnovici RM, Pintea IL, Mǎlǎescu DG, Busuioc CJ, Predescu A, Mogoantǎ L, Microscopic aspects of macrophage system cells in hemorrhagic stroke in humans, Rom J Morphol Embryol, 2011, 52(4):1249-1253.
44. Wang J, Doré S, Inflammation after intracerebral hemorrhage, J Cereb Blood Flow Metab, 2007, 27(5):894-908.
45. Wang J, Doré S, Heme oxygenase 2 deficiency increases brain swelling and inflammation after intracerebral hemorrhage, Neuroscience, 2008, 155(4):1133-1141.
46. Wang J, Fields J, Doré S, The development of an improved preclinical mouse model of intracerebral hemorrhage using double infusion of autologous whole blood, Brain Res, 2008, 1222:214-221.